Wockhardt reports consolidated net profit of Rs 1.77 cr in Q3

Drug maker Wockhardt on Thursday reported a consolidated net profit of Rs 1.77 crore for the third quarter of 2021

Wockhardt
Representative picture.
Press Trust of India New Delhi
1 min read Last Updated : Jan 27 2022 | 3:19 PM IST

Drug maker Wockhardt on Thursday reported a consolidated net profit of Rs 1.77 crore for the third quarter ended December 31, 2021.

The company had posted a net profit of Rs 32.4 crore in the same period of 2020-21 fiscal.

Income from continuing operations rose to Rs 853.89 crore in the third quarter as against Rs 764.02 crore in the October-December period of the previous fiscal, Wockhardt said in a regulatory filing.

The company said it plans to bring in a rights issue to raise upto Rs 1,000 crore.

"The objective of the Issue is to, inter alia, meet the company's financing needs for repayment of subordinated debt due, financing research and development initiatives, general corporate purposes and/or such other use of proceeds as may be permitted under the applicable laws," it added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :WockhardtQ3 resultsdrug manufacturers

First Published: Jan 27 2022 | 3:19 PM IST

Next Story